3Biotech
keyboard_backspaceBack to HomeContact
66 avenue des Champs-Elysées
75008 PARIS
France
EVP BD
About us
3Biotech is a consulting and support company for drug development projects. Our core business is CMC, and we support biotechs in all aspects of their development, right through to the end of phase 2 and transfer to phase 3. The company has been in existence for over 10 years, founded and run by OFB, who has a proven track record.
Business offer
To date, we have been involved in over 80 projects, 8 of which are in phase 1, 3 in phase 2 and 2 in phase 3. We support our customers right from the LEAD selection stage We work on all types of molecules: small molecules, antibodies, ADCs, Bi/ Tri specific, cell therapy, gene therapy, vaccines, .... In addition to our CMC activity, we are also regularly involved in the upstream and downstream stages of biotech capital raising.
Activities
- Service
- Immunotherapy lead optimization
- Engineering
- ADC
- Linkers
- Payloads
- Protein scaffolds
- Fragments
- Multi-, bispecific
- Fc-fusion proteins
- Indication Prioritization
- Antibody humanization
- Affinity maturation
- Proof of concept
- Pharmacology potency
- Exploratory toxicology
- in-vitro & ex-vivo models
- in-vivo models
- Cell expansion
- Gas permeable bags
- G-Rex bioreactors
- Wave-mixed bioreactors
- CMC
- GLP compliance
- GLP compliance
- Master Cell Bank
- Production
- Cell Line development
- Clone selection
- Characterization
- Storage
- Analytical development
- Cell Culture
- Media composition
- Bioreactor conditions
- Gene modification / Transduction
- Retroviral & lentiviral vectors
- Cell expansion
- Wave-mixed bioreactors
- Stirred tank reactors